Why is "Hypertriglyceridemia" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-30 16:50:34
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Hypertriglyceridemia is the presence of high amounts of triglycerides in the blood. Triglycerides are the most abundant fatty molecule in most organisms. Hypertriglyceridemia occurs in various physiologic conditions and in various diseases, and high triglyceride levels are associated with atherosclerosis, even in the absence of hypercholesterolemia and predispose to cardiovascular disease.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
EMA validates indication extension application for Tryngolza® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG) - finance.yahoo.com
-
Arrowhead Pharmaceuticals Presents New Long-Term Efficacy and Safety Data for Plozasiran Across a Spectrum of Hypertriglyceridemia at the American College of Cardiology’s 75th Annual Scientific Session and Expo - Arrowhead Pharmaceuticals, Inc.
-
Arrowhead's Plozasiran May Treat Hypertriglyceridemia, Offering Bigger Market Opportunity - Precision Medicine Online
-
Olezarsen for Managing Severe Hypertriglyceridemia and Pancreatitis Risk - NEJM
-
Long-term bezafibrate use shows promise for managing canine hypertriglyceridemia - DVM360
-
Screening Diagnosis and Management of Pediatric Hypertriglyceridemia - www.heart.org
-
ACC/AHA Dyslipidemia Guidelines Refocus Hypertriglyceridemia Treatment, With Viet Le, DMSc, PA-C - HCPLive
-
Abstract P238: The Economic Burden of Hypertriglyceridemia | Circulation: Cardiovascular Quality and Outcomes - ahajournals.org
-
LMF1 frameshift deletion in Franches-Montagnes horses with hypertriglyceridemia-induced pancreatitis - Nature
-
Severe Familial Chylomicronemia Syndrome With Refractory Hypertriglyceridemia and Multisystem Complications Managed With Chronic Plasmapheresis and Olezarsen: A Case Report - Cureus
-
Figure1 | Hypertriglyceridemia: its etiology, effects and treatment - CMAJ
-
Olezarsen Cuts Triglycerides, Pancreatitis Risk in Severe Hypertriglyceridemia - TCTMD.com
-
Olezarsen reduces triglyceride levels, pancreatitis risk in severe hypertriglyceridemia - healio.com
-
Reversible propofol resistance in a pediatric patient with chemotherapy-induced hypertriglyceridemia: a case report - Frontiers
-
Targeting APOC3 with Olezarsen in Moderate Hypertriglyceridemia - NEJM
-
Arrowhead Pharmaceuticals Receives FDA Breakthrough Therapy Designation for Plozasiran in Severe Hypertriglyceridemia - Arrowhead Pharmaceuticals, Inc.
-
Refractory Severe Hypertriglyceridemia With Insulin Resistance Treated by Early Therapeutic Plasma Exchange: A Case Report and Review of the Literature - Cureus
-
Olezarsen Proves Efficacy in Severe Hypertriglyceridemia, With Nicholas Marston, MD - HCPLive
-
FDA Accepts Olezarsen’s sNDA for Severe Hypertriglyceridemia, Grants Priority Review - HCPLive
-
Arrowhead Pharmaceuticals Presents Long-Term Data on Plozasiran Showing Consistent Triglyceride Reductions in Hypertriglyceridemia - geneonline.com
-
Olezarsen Significantly Reduces Triglycerides and Pancreatitis Risk in Severe Hypertriglyceridemia - Pharmacy Times
-
CORE/CORE2: Olezarsen Reaches Primary Endpoint for Severe Hypertriglyceridemia - HCPLive
-
The combined associations of excess body weight, hypertension, and hypertriglyceridemia with hyperglycemia among nondiabetic older adults in regional China - Nature
-
Evinacumab May Lower Triglycerides in Severe Hypertriglyceridemia, With Robert Rosenson, MD - HCPLive
-
Arrowhead Subsidiary Visirna Sells Rights to Hypertriglyceridemia Candidate Plozasiran in Greater China to Sanofi - Arrowhead Pharmaceuticals, Inc.
-
Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia - TCTMD.com
-
CORE/CORE2: Olezarsen Achieves Primary Endpoint in Severe Hypertriglyceridemia - HCPLive
-
Paclitaxel-Induced Hypertriglyceridemia Complicated by Acute Pancreatitis: A Case Report - Cureus
-
Omega-3 Fatty Acids for the Management of Hypertriglyceridemia - www.heart.org
-
Fatty acid analysis identifies an aberrant circulating triglyceride composition in patients with hypertriglyceridemia-induced acute pancreatitis | Scientific Reports - Nature
-
Hypertriglyceridemia: its etiology, effects and treatment - CMAJ
-
Groundbreaking pivotal study results of olezarsen for severe hypertriglyceridemia (sHTG) presented as a late breaker at AHA Scientific Sessions - finance.yahoo.com
-
Ionis receives U.S. FDA Breakthrough Therapy designation for olezarsen for severe hypertriglyceridemia (sHTG) - businesswire.com
-
Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion - fiercepharma.com
-
Ionis Cuts Trygolza Price Ahead Of Big New Indication - Citeline News & Insights
-
A retrospective study on LDL-C goal attainment in readmitted hypertriglyceridemia patients: risk factor analysis - Frontiers
-
TLR7 F507S gain-of-function mutation presenting with early-onset SLE and hypertriglyceridemia: Response to JAK inhibition - Rockefeller University Press
-
Arrowhead sells hypertriglyceridemia candidate rights in China - Pharmaceutical Technology
-
Case Report: Genetic testing reveals Wilson disease with familial hypertriglyceridemia in a 12-year-old boy - Frontiers
-
New medication reduced high triglyceride levels, improved cholesterol and liver health - www.heart.org
-
Plasmapheresis as a Life-Saving Measure for Severe Hypertriglyceridemia-Induced Acute Pancreatitis - Cureus
-
High-throughput screening reveals paeoniflorin’s efficacy against Apoc2-deficient hypertriglyceridemia via HNF4A/PPARA/LDLR - sciencedirect.com
-
Phosphate Improves Mitochondrial Function and Reduces Pancreatitis in Hypertriglyceridemia - Wiley
-
Targeting APOC3: A Potential New Tool for Managing Hypertriglyceridemia - Consultant360
-
GLP-1 Receptor Agonists Not Linked to Higher Pancreatitis or Cardiac Risk in Patients With High Triglycerides - Physician's Weekly
-
Ionis’ Tryngolza ‘Game-Changing' in Lowering Triglycerides, Cementing Case for FDA Filing - biospace.com
-
Ketosis-Prone Diabetes in Severe Hypertriglyceridemia-Induced Pancreatitis: A Case Report - Cureus
-
Potential influence of gut microbiota on the process of hypertriglyceridemia-aggravated acute pancreatitis - Baishideng Publishing Group
-
Piper Sandler Highlights Arrowhead Pharmaceuticals, Inc. (ARWR) Pipeline With Upcoming Phase III Hypertriglyceridemia Data - finance.yahoo.com
-
Olezarsen Brings Moderately High Triglycerides Under Control: ESSENCE-TIMI 73b - TCTMD.com
-
Ionis reports positive data from study of olezarsen for hypertriglyceridemia - Clinical Trials Arena
-
Arrowhead Pharmaceuticals Completes Enrollment in SHASTA-3, SHASTA-4, and MUIR-3 Phase 3 Studies of Plozasiran - Arrowhead Pharmaceuticals, Inc.
-
OrsoBio Announces Positive Topline Phase 2a Data for LXR Inverse Agonist TLC-2716 in Severe Hypertriglyceridemia and Metabolic Liver Disease - biospace.com
-
Ionis hits it out of the park with data for Tryngolza in severe blood fat disease - fiercepharma.com
-
The role of intestinal microbiota and its metabolite short-chain fatty acids in hypertriglyceridemia-associated acute pancreatitis - Frontiers
-
AACE Updates Guidelines for Pharmacologic Management of Dyslipidemia in Adults - Endocrinology Advisor
-
Impaired central sensitivity to thyroid hormone is associated with hypertriglyceridemia in euthyroid population - Frontiers
-
Hypertriglyceridemia as a Key Contributor to Abdominal Aortic Aneurysm Development and Rupture: Insights From Genetic and Experimental Models - ahajournals.org
-
Olezarsen significantly reduces triglycerides and acute pancreatitis events in landmark pivotal studies for people with severe hypertriglyceridemia (sHTG) - finance.yahoo.com
-
Triglyceride-lowering drug can also decrease the risk of acute pancreatitis - News-Medical
-
Severe Hypertriglyceridemia-Induced Pancreatitis Presenting as Diabetic Ketoacidosis in a Young Adult With Type 2 Diabetes Mellitus - Cureus
-
Olezarsen cut triglycerides by 60% in patients with heightened cardiovascular risk - healio.com
-
Triglyceride levels substantially reduced with olezarsen compared to placebo - News-Medical
-
Novel GLP-1 Drug on Attack Path Against Very High Triglycerides - MedPage Today
-
Case Report: Non-Catheter-Related arterial hemorrhage as a complication of hemoperfusion in hypertriglyceridemic pancreatitis: mechanistic hypotheses and multidisciplinary strategies - Frontiers
-
Case Report: Morphologically striking eruptive xanthomas with lobulated papules: a sentinel sign of severe metabolic dysregulation - Frontiers
-
FDA accepts olezarsen application for severe hypertriglyceridemia - Investing.com
-
Triglycerides identified as direct cause of abdominal aortic aneurysms - News-Medical
-
Press Release Service: Mammoth Biosciences to Present Preclinical Data on MB-111 at the European Society of Gene & Cell Therapy 32nd Annual Congress - CRISPR Medicine News
-
Ionis chalks up phase 3 trial win as it works to grow the reach of Tryngolza - fiercepharma.com
-
Ionis Pharmaceuticals Repriced Drug Ahead Of Key FDA Decision Signals Push Into Larger Market - Benzinga
-
Groundbreaking Cardiometabolic Trials Presented at the AHA Scientific Sessions - The Cardiology Advisor
-
OrsoBio’s LXR inverse agonist shows promise for hard-to-treat triglyceride disorders - drugdiscoverytrends.com
-
Case Report: POEMS syndrome secondary to multiple solitary plasmacytomas complicated by hypertriglyceridemia - Frontiers
-
High triglycerides drive life threatening aortic aneurysms, study in mice finds - michiganmedicine.org
-
Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN Registry - ahajournals.org
-
Developing a Core Outcome Set for blood purification in hypertriglyceridemic acute pancreatitis: a Delphi study protocol - Frontiers
-
The impact of hyperinsulinemia on short-term prognosis in patients with hypertriglyceridemia-induced acute pancreatitis - Frontiers
-
Can Heparin Improve Hypertriglyceridemic Pancreatitis Care? - Medscape
-
RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia - evidence.nejm.org
-
Olezarsen reduces levels of the blood fat, triglycerides, in patients at high cardiovascular risk: Clinical trial - Medical Xpress
-
Non-remnant triglyceride-rich lipoproteins due to lipoprotein lipase deficiency increase atherosclerosis in mice - Nature
-
Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk - NEJM
-
Is Genetic Testing in Hypertriglyceridemia Useful? - ahajournals.org
-
Genetic Testing for Hypertriglyceridemia in Academic Lipid Clinics: Implications for Precision Medicine—Brief Report - ahajournals.org
-
Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN Registry - ahajournals.org
-
Intermountain Study Shows Weight Loss Drugs Don’t Increase Risk of Pancreatitis or Adverse Cardiac Events in Patients with High Triglycerides - Intermountain Health
-
ST Pharm inks $56M deal to produce API for a US biotech - fiercepharma.com
-
Ionis Pharmaceuticals, Inc. (IONS) Discusses Detailed Phase III Results for Olezarsen in Severe Hypertriglyceridemia - Slideshow (NASDAQ:IONS) 2025-11-10 - seekingalpha.com
-
Hypertriglyceridemia and Atherosclerosis: Using Human Research to Guide Mechanistic Studies in Animal Models - Frontiers
-
Ionis Pharmaceuticals (IONS) Is Up 43.6% After Positive Phase 3 Olezarsen Results in Severe Hypertriglyceridemia – Has the Bull Case Changed? - finance.yahoo.com
-
NLA 2025: ApoC3 Inhibitors Show Promise Across a Spectrum of Hypertriglyceridemic Disorders - Pharmacy Times
-
Association between high triglyceride-glucose index and MACCE in hypertriglyceridemia patients undergoing percutaneous coronary intervention - Frontiers
-
Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial - Nature
-
Omega 3 Prescription Drugs Market Size, Share | CAGR of 7.8% - Market.us
-
Ionis reports success in olezarsen trial for high triglycerides - Clinical Trials Arena
-
Case Report: Severe hypertriglyceridaemia and multivessel coronary artery disease – management and plaque characteristics - Frontiers
-
New Drug Slashes Dangerous Blood Fats by Nearly 40% in First Human Trial - SciTechDaily
-
Arrowhead sells rights of Hypertriglyceridemia candidate to Sanofi in Greater China for $265 M - BioSpectrum Asia
-
Ionis reports topline outcomes from Phase III trials of olezarsen for sHTG - Clinical Trials Arena
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.